Financhill
Buy
68

DBD Quote, Financials, Valuation and Earnings

Last price:
$68.83
Seasonality move :
6.94%
Day range:
$67.10 - $68.63
52-week range:
$34.88 - $69.23
Dividend yield:
0%
P/E ratio:
50.09x
P/S ratio:
0.69x
P/B ratio:
2.21x
Volume:
155.3K
Avg. volume:
207.2K
1-year change:
57.83%
Market cap:
$2.5B
Revenue:
$3.8B
EPS (TTM):
$1.36

Earnings Data

Next earnings date for DBD
Feb 11
2026
Most recent earnings per share
$1.11
Beat by $0.18
(Nov 5/2025)
Consensus Estimate
$0.93
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

DBD Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/11/2026 Q4 $1.1B -- -- $1.65 --
11/05/2025 Q3 $937.6M $945.2M $1.11 $0.93 $0.18
08/06/2025 Q2 $879.6M $915.2M $0.33 $0.58 -$0.26
05/07/2025 Q1 $844.1M $841.1M -$0.22 $0.36 -$0.58
02/12/2025 Q4 $988M $988.9M $0.15 $1.06 -$0.91
11/07/2024 Q3 $929.5M $927.1M -$0.60 $1.14 -$1.74
08/07/2024 Q2 $913.5M $939.7M $0.40 $1.05 -$0.65
05/02/2024 Q1 $875.7M $895.4M -$0.39 $0.23 -$0.62
02/14/2024 Q4 $1B $2.2B $0.59 $1.43 -$0.84
11/09/2023 Q3 -- $943.4M $57.02 -- --
06/30/2023 Q2 -- $922.2M -$8.46 -- --
03/31/2023 Q1 -- $858.1M -$1.40 -- --
12/31/2022 Q4 -- $968.8M -$1.89 -- --
09/30/2022 Q3 -- $810.4M -$0.63 -- --
06/30/2022 Q2 -- $851.7M -$2.52 -- --
03/31/2022 Q1 -- $829.8M -$2.33 -- --
12/31/2021 Q4 -- $1.1B -$0.49 -- --
09/30/2021 Q3 -- $958.2M -$0.03 -- --
06/30/2021 Q2 -- $943.5M -$0.39 -- --
03/31/2021 Q1 -- $943.9M -$0.10 -- --
12/31/2020 Q4 -- $1.1B -$0.66 -- --
09/30/2020 Q3 -- $994.8M -$1.31 -- --
06/30/2020 Q2 -- $890.3M -$0.31 -- --
03/31/2020 Q1 -- $910.4M -$1.20 -- --
12/31/2019 Q4 -- $1.2B -$1.60 -- --
09/30/2019 Q3 -- $1.1B -$0.46 -- --
06/30/2019 Q2 -- $1.2B -$0.66 -- --
03/31/2019 Q1 -- $1B -$1.74 -- --
12/31/2018 Q4 -- $1.3B -$1.62 -- --
09/30/2018 Q3 -- $1.1B -$3.13 -- --
06/30/2018 Q2 -- $1.1B -$1.76 -- --
03/31/2018 Q1 -- $1.1B -$0.97 -- --
12/31/2017 Q4 -- $1.2B -$1.46 -- --
09/30/2017 Q3 -- $1.1B -$0.48 -- --
06/30/2017 Q2 -- $1.1B -$0.41 -- --
03/31/2017 Q1 -- $1.1B -$0.78 -- --
12/31/2016 Q4 -- $1.2B -$1.04 -- --
09/30/2016 Q3 -- $983.3M -$1.38 -- --
06/30/2016 Q2 -- $580M -$0.33 -- --
03/31/2016 Q1 -- $509.6M $0.29 -- --
12/31/2015 Q4 -- $615.4M $0.54 -- --

Diebold Nixdorf, Inc. Earnings Questions

  • How Much did Diebold Nixdorf, Inc. Generate in Revenue Last Quarter?

    Diebold Nixdorf, Inc. reported $945.2M worth of top line sales in its most recent quarter.

  • Did Diebold Nixdorf, Inc. Beat Earnings Last Quarter?

    Diebold Nixdorf, Inc. announced earnings per share of $1.11 which represents a beat of analyst forecast a $0.93 per share.

  • Is Diebold Nixdorf, Inc. Profitable?

    Diebold Nixdorf, Inc. reported $247.9M that represents $6.70 per share over the last quarter.

  • What is the Analyst Consensus for Diebold Nixdorf, Inc. EPS Next Year?

    Diebold Nixdorf, Inc.'s earnings are forecast to decrease from -$0.44 per share to $3.72 per share next year representing a decrease of -89.85%.

  • When is Diebold Nixdorf, Inc.'s Earnings Date?

    Diebold Nixdorf, Inc.'s next earnings date is February 11, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
60
AAOI alert for Dec 24

Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.

Buy
85
HUT alert for Dec 24

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
63
GPCR alert for Dec 24

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock